Clinical impact of carbon dioxide insufflation during ERCP; A phase 3, open-label, randomized controled trial.

Clinical impact of carbon dioxide insufflation during ERCP; A phase 3, open-label, randomized controled trial. - Carbon dioxide insufflation during ERCP

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005755

Enrollment

100

Registered

2011-07-01

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreato-biliary disease

Interventions

CO2 insufflation air insufflation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pancreato-biliary disease, ERCP required

Exclusion criteria

Exclusion criteria: inability to provide informed consent chronic obstructive pulmonary disease severe abdominal pain before ERCP pregnancy

Design outcomes

Primary

Measure	Time frame
Visual analogue scale (VAS)	—

Secondary

Measure	Time frame
change of waist size duration of sedative effect safety	—

Countries

Japan

Contacts

Public ContactTESSHIN BAN

Nagoya daini red cross hospital gastroenterology

052-832-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026